Can the Energetic Profile of Skeletal Muscle Predict Risk of Cognitive Impairment?
Open Access
- 9 November 2021
- journal article
- editorial
- Published by American Physiological Society in Function
- Vol. 2 (6) , zqab057
Abstract
Alzheimer's disease (ad) is one of the most common neurodegenerative disorders that affects memory, thinking, and behavior, as humans age. ad is a complex, multifactorial condition that lacks many treatment options from a clinical perspective. Further complicating treatment of AD is the presence of other secondary issues such as peripheral insulin resistance, low physical activity, high blood pressure, obesity, and so on. Thus, clinicians are tasked with diagnosing patients without proven basic scientific analytical tools while the patient is presenting with other clinical issues.Keywords
This publication has 8 references indexed in Scilit:
- Peripheral Nerve Impairment in a Mouse Model of Alzheimer’s DiseaseBrain Sciences, 2021
- Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal MuscleFunction, 2021
- Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer’s diseaseMitochondrion, 2021
- NAD+ boosting reduces age-associated amyloidosis and restores mitochondrial homeostasis in muscleCell Reports, 2021
- Mitochondrial Diagnostics: A Multiplexed Assay Platform for Comprehensive Assessment of Mitochondrial Energy FluxesCell Reports, 2018
- Mitochondrial oxygen consumption deficits in skeletal muscle isolated from an Alzheimer’s disease-relevant murine modelBMC Neuroscience, 2014
- Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscleNeurobiology of Aging, 2010
- Elevated Aβ42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of AβPP MetabolismThe American Journal of Pathology, 2000